These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2366638)

  • 1. A comparative study of manganese meso-sulfonatophenyl porphyrins: contrast-enhancing agents for tumors.
    Fiel RJ; Musser DA; Mark EH; Mazurchuk R; Alletto JJ
    Magn Reson Imaging; 1990; 8(3):255-9. PubMed ID: 2366638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
    Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
    Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice.
    Furmanski P; Longley C
    Cancer Res; 1988 Aug; 48(16):4604-10. PubMed ID: 3396012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-selective contrast enhancing agent, Mn(III)meso- [tri(4-sulfonatophenyl)phenyl]porphine (MnTPPS3).
    Fiel R; Mark E; Button T; Gilani S; Musser D
    Magn Reson Imaging; 1993; 11(7):1079-81. PubMed ID: 8231675
    [No Abstract]   [Full Text] [Related]  

  • 5. MRI contrast-dose relationship of manganese(III)tetra(4-sulfonatophenyl) porphyrin with human xenograft tumors in nude mice at 2.0 T.
    Place DA; Faustino PJ; Berghmans KK; van Zijl PC; Chesnick AS; Cohen JS
    Magn Reson Imaging; 1992; 10(6):919-28. PubMed ID: 1461089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution and stability of metalloporphyrin MRI contrast agents.
    Lyon RC; Faustino PJ; Cohen JS; Katz A; Mornex F; Colcher D; Baglin C; Koenig SH; Hambright P
    Magn Reson Med; 1987 Jan; 4(1):24-33. PubMed ID: 3821476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the localization of manganese (III) mesotetra(4-sulfonatophenyl)porphine in mice bearing L1210 tumors.
    Fiel RJ; Mark E; Button T; Gilani S; Musser D
    Cancer Lett; 1988 May; 40(1):23-32. PubMed ID: 3370627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MnPcS4: a new MRI contrast enhancing agent for tumor localisation in mice.
    Saini SK; Jena A; Dey J; Sharma AK; Singh R
    Magn Reson Imaging; 1995; 13(7):985-90. PubMed ID: 8583877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
    El-Far M; Pimstone N
    Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, toxicity and biodistribution of two 5,15-di[3,5-(nido-carboranylmethyl)phenyl]porphyrins in EMT-6 tumor bearing mice.
    Vicente MG; Wickramasinghe A; Nurco DJ; Wang HJ; Nawrocky MM; Makar MS; Miura M
    Bioorg Med Chem; 2003 Jul; 11(14):3101-8. PubMed ID: 12818672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma.
    Peng Q; Moan J; Ma LW; Nesland JM
    Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Applications of Porphyrins and Metalloporphyrins in Biomedicine and Diagnostic Magnetic Resonance Imaging.
    Imran M; Ramzan M; Qureshi AK; Khan MA; Tariq M
    Biosensors (Basel); 2018 Oct; 8(4):. PubMed ID: 30347683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats.
    Schmiedl UP; Nelson JA; Starr FL; Schmidt R
    Invest Radiol; 1992 Jul; 27(7):536-42. PubMed ID: 1644554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice.
    Patronas NJ; Cohen JS; Knop RH; Dwyer AJ; Colcher D; Lundy J; Mornex F; Hambright P; Sohn M; Myers CE
    Cancer Treat Rep; 1986 Mar; 70(3):391-5. PubMed ID: 3955550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice.
    Wu H; Micca PL; Makar MS; Miura M
    Bioorg Med Chem; 2006 Aug; 14(15):5083-92. PubMed ID: 16651000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-free T1 contrast agents for MRI: tunable pharmacokinetics of a new class of manganese porphyrins.
    Cheng HL; Haedicke IE; Cheng W; Tchouala Nofiele J; Zhang XA
    J Magn Reson Imaging; 2014 Dec; 40(6):1474-80. PubMed ID: 24214904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma.
    Peng Q; Moan J; Warloe T; Nesland JM; Rimington C
    Int J Cancer; 1992 Sep; 52(3):433-43. PubMed ID: 1399120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.